Kimia Farma Persero Tbk (KAEF) - Total Assets

Latest as of June 2026: Rp14.70 Trillion IDR ≈ $861.25 Million USD

Based on the latest financial reports, Kimia Farma Persero Tbk (KAEF) holds total assets worth Rp14.70 Trillion IDR (≈ $861.25 Million USD) as of June 2026. Total assets represent everything the company owns and controls, combining both current assets—like cash and cash equivalents, accounts receivable, and inventories—and non-current assets such as property, plant, equipment (PP&E), intangible assets, and long-term investments.

Kimia Farma Persero Tbk - Total Assets Trend (2002–2025)

This chart illustrates how Kimia Farma Persero Tbk's total assets have evolved over time, based on quarterly financial data. Also see how much is Kimia Farma Persero Tbk worth for the company's overall valuation and market capitalisation.

Kimia Farma Persero Tbk - Asset Composition Analysis

Current Asset Composition (December 2025)

Kimia Farma Persero Tbk's total assets of Rp14.70 Trillion consist of 28.1% current assets and 71.9% non-current assets. Review Kimia Farma Persero Tbk balance sheet liabilities to assess the company's total debt and financial obligations.

Asset Category Amount (IDR) % of Total Assets
Cash & Equivalents Rp70.37 Billion 4.6%
Accounts Receivable Rp1.21 Trillion 8.5%
Inventory Rp1.38 Trillion 9.7%
Property, Plant & Equipment Rp8.65 Trillion 61.0%
Intangible Assets Rp48.77 Billion 0.3%
Goodwill Rp53.68 Billion 0.4%

Asset Composition Trend (2002–2025)

This chart illustrates how Kimia Farma Persero Tbk's asset composition has evolved over time. Understanding changes in asset allocation can provide insights into the company's strategic shifts, capital allocation priorities, and business focus evolution. See Kimia Farma Persero Tbk stock price for real-time trading data and today's change.

Key Asset Composition Facts

  • Current vs. Non-Current Assets: Kimia Farma Persero Tbk's current assets represent 28.1% of total assets in 2025, an increase from 0.0% in 2002.
  • Cash Position: Cash and equivalents constituted 4.6% of total assets in 2025, down from 11.6% in 2002.
  • Tangible vs. Intangible: Intangible assets (including goodwill) make up 0.0% of total assets, unchanged from 0.0% in 2002.
  • Asset Diversification: The largest asset category is property, plant & equipment at 61.0% of total assets.

Kimia Farma Persero Tbk Competitors by Total Assets

Key competitors of Kimia Farma Persero Tbk based on total assets are shown below.

Company Country Total Assets
Sigma Healthcare Limited
F:S5YA
Germany €1.83 Billion
Sigma Healthcare Ltd
AU:SIG
Australia AU$8.74 Billion
Ebos Group Ltd
AU:EBO
Australia AU$8.80 Billion
Mayne Pharma Group Ltd
AU:MYX
Australia AU$1.01 Billion
Paragon Care Ltd
AU:PGC
Australia AU$1.31 Billion
Profarma Distribuidora de Produtos Farmacêuticos S.A
SA:PFRM3
Brazil R$5.64 Billion
Shanghai Pharmaceuticals Holding Co Ltd
SHG:601607
China CN¥235.37 Billion
Guangzhou Baiyunshan Pharmaceutical Holdings Co Ltd
SHG:600332
China CN¥89.76 Billion

Kimia Farma Persero Tbk - Liquidity and Working Capital Analysis

Liquidity ratios measure a company's ability to pay off its short-term debts as they come due, using the company's current or quick assets. Working capital represents the operational liquidity available.

Key Liquidity Metrics

Metric Current 1 Year Ago 5 Years Ago
Current Ratio 1.03 0.59 1.01
Quick Ratio 0.72 0.39 0.53
Cash Ratio 0.00 0.00 0.00
Working Capital Rp157.19 Billion Rp-2.80 Trillion Rp103.32 Billion

Kimia Farma Persero Tbk - Advanced Valuation Insights

This section examines the relationship between Kimia Farma Persero Tbk's asset base and its market valuation, helping to identify whether the company's assets are efficiently translated into market value.

Key Valuation Metrics

Current Price-to-Book Ratio 1.45
Latest Market Cap to Assets Ratio 0.00
Asset Growth Rate (YoY) -5.2%
Total Assets Rp14.18 Trillion
Market Capitalization $144.17 Million USD

Valuation Analysis

Below Book Valuation: The market values Kimia Farma Persero Tbk's assets below their book value (0.00x), which may indicate investor concerns about asset quality or future growth.

Significant Asset Reduction: Kimia Farma Persero Tbk's assets decreased by 5.2% over the past year, potentially indicating divestiture, restructuring, or challenging business conditions.

Annual Total Assets for Kimia Farma Persero Tbk (2002–2025)

The table below shows the annual total assets of Kimia Farma Persero Tbk from 2002 to 2025.

Year Total Assets Change
2025-12-31 Rp14.18 Trillion
≈ $831.08 Million
-5.24%
2024-12-31 Rp14.97 Trillion
≈ $877.01 Million
-14.89%
2023-12-31 Rp17.59 Trillion
≈ $1.03 Billion
-13.60%
2022-12-31 Rp20.35 Trillion
≈ $1.19 Billion
+14.60%
2021-12-31 Rp17.76 Trillion
≈ $1.04 Billion
+1.12%
2020-12-31 Rp17.56 Trillion
≈ $1.03 Billion
-4.30%
2019-12-31 Rp18.35 Trillion
≈ $1.08 Billion
+94.00%
2018-12-31 Rp9.46 Trillion
≈ $554.34 Million
+55.19%
2017-12-31 Rp6.10 Trillion
≈ $357.21 Million
+32.16%
2016-12-31 Rp4.61 Trillion
≈ $270.28 Million
+42.53%
2015-12-31 Rp3.24 Trillion
≈ $189.63 Million
+9.03%
2014-12-31 Rp2.97 Trillion
≈ $173.92 Million
+20.08%
2013-12-31 Rp2.47 Trillion
≈ $144.85 Million
+19.05%
2012-12-31 Rp2.08 Trillion
≈ $121.67 Million
+15.72%
2011-12-31 Rp1.79 Trillion
≈ $105.14 Million
+8.26%
2010-12-31 Rp1.66 Trillion
≈ $97.11 Million
+6.06%
2009-12-31 Rp1.56 Trillion
≈ $91.56 Million
+8.09%
2008-12-31 Rp1.45 Trillion
≈ $84.71 Million
+4.25%
2007-12-31 Rp1.39 Trillion
≈ $81.26 Million
+9.95%
2006-12-31 Rp1.26 Trillion
≈ $73.90 Million
+7.10%
2005-12-31 Rp1.18 Trillion
≈ $69.00 Million
+0.35%
2004-12-31 Rp1.17 Trillion
≈ $68.76 Million
-14.14%
2003-12-31 Rp1.37 Trillion
≈ $80.09 Million
+31.60%
2002-12-31 Rp1.04 Trillion
≈ $60.85 Million
--

About Kimia Farma Persero Tbk

JK:KAEF Indonesia Medical Distribution
Market Cap
$144.17 Million
Rp2.46 Trillion IDR
Market Cap Rank
#17885 Global
#282 in Indonesia
Share Price
Rp442.00
Change (1 day)
+0.45%
52-Week Range
Rp390.00 - Rp715.00
All Time High
Rp6895.27
About

PT Kimia Farma Tbk, together with its subsidiaries, manufactures and sells a range of medicines in Indonesia and internationally. It operates through Manufacture, Distribution, Retail, and Others segments. The company offers drugs in the form of tablets, effervescent tablets, hard and soft capsules, liquids, syrups, oral powders, non-beta-lactam external liquids, beta-lactam tablets and dry syrup… Read more